Latest

Read More

Vycellix Founders Awarded Major Swedish Grant to Establish NextGen-NK

Vycellix Founders Awarded Innovation Grant by Sweden’s Vinnova to Establish New World-Class Research Environment on Development of Next-Generation Natural Killer Cell-based Cancer Immunotherapy Vycellix included as collaborative partner within the Center’s research constellation of prestigious academic & industry partners TAMPA, FLORIDA & STOCKHOLM, SWEDEN – June 27, 2019 – Vycellix™, Inc. today announced that the […]

Read More

Vycellix Announces Formation of Scientific Advisory Board

SAB Comprised of Key Opinion Leaders Advancing Next-Generation Cell & Gene-based Immuno-Oncology Therapeutic Platforms TAMPA, FLORIDA & STOCKHOLM, SWEDEN – June 25, 2019 – Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, has appointed the inaugural members of its Scientific Advisory Board (SAB). Vycellix’s SAB […]

Read More

Vycellix CEO to Present Strategies for Enhancing Next-Generation NK Cell Cancer Therapy at Innate Killer Summit

TAMPA, FLORIDA & STOCKHOLM, SWEDEN – March 15, 2019 – Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, will present at the Innate Killer Summit 2019 to be held in San Diego, March 20-21. On Wednesday, March 20th at 4:20pm PT, Vycellix’s founding CEO, Evren […]